Results 231 to 240 of about 11,335 (243)
Some of the next articles are maybe not open access.
Property-based optimisation of PROTACs
RSC Medicinal ChemistryPROTACs are an emerging therapeutic approach towards targeted protein degradation. This article examines the leading examples of this modality that are in clinical development through the prism of their physicochemical properties.James S. Scott, Iacovos N. Michaelides, Markus Schade +2 moreopenaire +2 more sourcesA BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
Nature AgingYang Yang, Natacha Jn-Simon, Yonghan He, Chunbao Sun, Peiyi Zhang, Wanyi Hu, Tian Tian, Huadong Zeng, Sreenivasulu Basha, Araceli S. Huerta, Lu-Zhe Sun, X. Yin, R. Hromas, Guangrong Zheng, Liya Pi, Daohong Zhou +15 moresemanticscholar +1 more sourceTumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
Acta Pharmacologica SinicaZhifeng Zou, Lei Yang, Hui-jun Nie, Jing Gao, Shumin Lei, Yi Lai, Fan Zhang, Ernst Wagner, Haijun Yu, Xiao-hua Chen, Zhiai Xu +10 moresemanticscholar +1 more source